Xeris Biopharma Holdings (XERS) Long-Term Investments (2020 - 2021)
Xeris Biopharma Holdings (XERS) reported Long-Term Investments of $33.5 million for Q3 2021, down 65.18% quarter-over-quarter from $96.2 million in Q4 2020.
Xeris Biopharma Holdings (XERS) Long-Term Investments (2020 - 2021) Analysis & Trends
Xeris Biopharma Holdings has reported Long-Term Investments for 2 years, with the latest figure at $33.5 million in Q3 2021.
- For the quarter ending Q3 2021, Long-Term Investments changed N/A year-over-year to $33.5 million; the trailing twelve-month figure through Sep 2021 stood at $33.5 million (changed N/A YoY), and the FY2020 full-year result was $96.2 million, changed N/A from the prior year.
- Long-Term Investments for Q3 2021 stood at $33.5 million, down from $96.2 million in the prior quarter.
- The five-year high for Long-Term Investments was $96.2 million in Q4 2020, with the low at $33.5 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.90 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 33.49 Mn |
| Dec 31, 2020 | 96.19 Mn |